This peer-reviewed journal provides cutting-edge research on therapeutic investigations and advancements in radioimmunotherapy for treating cancer. It is the only journal with a specific focus on cancer biotherapy and is inclusive of monoclonal antibodies, cytokine therapy, cancer gene therapy, cell-based therapies, and other forms of immunotherapies. View full journal description
Browse by
Articles most recently published online for this journal.
Most read articles in this journal in the last 6 months.
Most cited articles published in this journal in the last 3 years. These statistics are updated weekly using data sourced exclusively from CrossRef.
Articles with the highest Altmetric score from the last 3 months, indicating influence and impact.
You might be interested in
Special Issue Call for Papers
Submit to the Special Issue on Radionuclide Therapy for Precision Oncology: Radiopharmaceutical Design, Clinical Outcomes and Opportunities
Submission Deadline: August 31, 2026
Special Issue Call for Papers
Submit to the Special Issue on Advances in Bioorganic Molecules for Anticancer Drug Development
Submission Deadline: July 15, 2026
Publish with us
Authors will enjoy:
- Rigorous peer review of your research
- Prompt publishing
- Multidisciplinary audience
- High visibility for global exposure
Sage discipline hubs
Explore the content from across our disciplines, including the latest journal articles, special issues, and related books and digital library content.
Facebook
X
LinkedIn
YouTube
RSS feed
Email alerts